About: Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.25 (+4.17%)
PAR ASX Paradigm Biopharmaceuticals Ltd
Paradigm Biopharmaceuticals Ltd share price
PAR price activity
Last Price
$0.250
Change (24hr)
0.01 AUD (4.17%)
Volume
1.75M
Volume (4w avg)
-
Open
$0.24
Day Range
$0.24 - $0.26
Previous Close
$0.24
Last Trade
15 Sep, 7:17 am GMT+0
Delayed
15 Sep, 7:17 am GMT+0
PAR price performance
Delayed
15 Sep, 7:17 am GMT+0
PAR Market Signals